Regeneron Pharmaceuticals confirms its acquisition of 23andMe, the once-prominent consumer genetic testing firm, for $256 million through a bankruptcy auction. The transaction …
@2023 – All Right Reserved. Designed and Developed by:
Christopher Leonard – OMG Media Partners, LLC.